Description
Global Stem Cell Therapy Market Forecast till 2027
Market Overview
The stem cell therapy market is expected to attain a significant CAGR of 10.74% during the review period of 2020 to 2027.
Stem cell therapy is used to cure any disease. The global market growth is attributed to the rising prevalence of chronic diseases, expanding healthcare industry, and the growing expenditure on medical research. Additionally, the increasing number of clinical studies for stem cell therapy are fuelling the global market growth during the review period.
The global stem cells therapy market is expected to register a healthy market expansion during the forecast period owing to the largest market value of USD 5,735.12 million in 2020.
Moreover, an increment in the number of clinical investigations for stem cell therapy is, driving the market development. In any case, the moral worries identified with early-stage stem cell-based treatments and the related significant expenses might hamper the stem cell therapy market development in the future.
Market Segmentation
The stem cell therapy market has been classified in terms of cell source, type, application, and end-user.
Based on cell source the market is classified into adipose tissue, bone marrow, embryo/cord blood-derived, neural, IPSCs, and PSCs.
Based on type, the stem cell therapy market is divided into allogenic and autologous.
By application, the market is classified into diabetes, musculoskeletal disorders, cancer, cardiovascular disorders, gastrointestinal diseases, and others.
In terms of end-user, the global market is categorized into hospitals & clinics, academic research centers, and others.
Regional Analysis
Geographically the stem cell therapy market is spread across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The expanded public-private financing and exploration awards for delivering protected and successful stem cell therapy items and the presence of central members in the locale are the main considerations driving America’s stem cell therapy market.
Europe holds the second biggest portion of the overall industry because of an increment in the eagerness of patients to go through stem cell therapy and a developing number of instances of persistent and neurological problems.
Asia-Pacific is the quickest developing territorial market for stem cell treatments as it is growing quickly and has seen the rise of numerous players. In addition, the rising pervasiveness of disease, and developing reception of stem cell therapy medicines in the area, are probably going to drive the market’s development.
The stem cell therapy market in the Middle East& Africa is relied upon to observe confined development because of an absence of public mindfulness and restricted reasonableness among the populace. Be that as it may, some regenerative medication applications are occurring in the Gulf nations.
Major Players
The key companies listed in the stem cell therapy market report Seraxis, Inc. (Germany), ViaCyte, Inc. (the US), Betalin Therapeutics Ltd (Israel), 4.NextCell Pharma AB (US), Kadimastem (Israel), Vertex Pharmaceuticals (US), Fresenius Medical Care AG & Co. KGaA (Germany), Sernava Corp (Canada), Novo Nordisk A/S (Denmark), and Generex Biotechnology (Canada).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.
Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Related:
Global Placental Stem Cell Therapy Market 2029
Cell Therapy Technologies Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030
